KTKokeb Tesfamariam

Kokeb Tesfamariam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kokeb Tesfamariam has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessment of mycotoxin exposure in rural Tanzania: Human biomonitoring using urine and volumetric absorptive microsampling

    by Sambwe Fundikira, Martin Kimanya, Rashid Suleiman, An Chen, Elias Maris, Marthe De Boevre, Kokeb Tesfamariam, Sarah De Saeger

  • Open Access

    Long-Term Effects of Multiple-Micronutrient Supplementation During Pregnancy, Lactation, and Early Childhood on the Cognitive Development of Children Aged 4–14 Years: A Systematic Review of Randomized Controlled Trials

    by Arnold William, Carl Lachat, Dimitrios Petalios, Alice Deshons, Kokeb Tesfamariam Hadush, Mélanie Broin, Souheila Abbeddou

    Background: Inadequate nutrition, poor health care, and limited stimulation constrain early childhood development and cognitive potential. Micronutrient deficiencies during pregnancy and early life are prevalent in low- and middle-income countries (LMICs) and may impair cognitive outcomes. Maternal multiple-micronutrient (MMN) and point-of-use micronutrient powder (MNP) supplements improve birth outcomes and iron status, but their long-term cognitive impact remains unclear. This systematic review assessed the long-term impact of maternal MMN and early-childhood MNP supplementation on cognitive development among children aged 4–14 years in LMICs. Method: Following PRISMA guidelines (PROSPERO CRD42023459846), (cluster) randomized controlled trials were identified from six databases and gray literature (October 2023; updated July 2025). Records were managed in EndNote and screened in Covidence, and data were synthesized using Review Manager. Eligible studies examined MMN or MNP interventions during pregnancy, lactation, or early childhood, reporting cognitive, motor, or socio-emotional outcomes in children aged 4–14. Results: Ten studies met the inclusion criteria: six on maternal supplementation, three on early childhood interventions, and one combining both. Most were conducted in Asia, with one in Tanzania and one in Peru. Although most findings were not statistically significant, two large UNIMMAP-based trials indicated modest long-term improvements in procedural memory and intelligence, while one early childhood point-of-use MNP trial suggested enhanced pre-academic skills. Conclusions: Maternal MMN supplementation may modestly enhance specific domains of cognitive development, whereas evidence on the long-term effects of MMN and point-of-use MNPs on cognitive development remain limited, highlighting the necessity for further research.


  • Open Access

    Nutritional benefits, technological innovations and safety of fermented cereal products: Insights from umqombothi

    by Lungani Amanda Nyathi, Patrick Berka Njobeh, Bhekisisa Dlamini, Kokeb Tesfamariam, Sarah De Saeger, Francesca Valerio, Giuseppina Avantaggiato, Oluwakamisi Festus Akinmoladun, Gabriel Bidemi Akanni, Oluwafemi Ayodeji Adebo


  • Open Access

    Long-Term Effects of Multiple Micronutrient Supplementation During Pregnancy, Lactation, and Early Childhood on the Cognitive Development of Children Aged 4 –14 Years: A Systematic Review of Randomized Controlled Trials

    by Arnold William, Carl Lachat, Dimitrios Petalios, Alice Deshons, Kokeb Tesfamariam Hadush, Mélanie Broin, Souheila Abbeddou

    Background: Inadequate nutrition, poor health care, and limited stimulation constrain early childhood development and cognitive potential. Micronutrient deficiencies during pregnancy and early life are prevalent in low- and middle-income countries (LMICs) and may impair cognitive outcomes. Maternal multiple micronutrient (MMN) and point-of-use micronutrient powders (MNP) supplements improve birth outcomes and iron status, but their long-term cognitive impact remains unclear. This systematic review assessed the long-term impact of maternal MMN and early-childhood MNP supplementation on cognitive development among children aged 4–14 years in LMICs. Method: Following PRISMA guidelines (PROSPERO CRD42023459846), (cluster) randomized controlled trials were identified from six databases and gray literature (October 2023; updated July 2025). Records were managed in EndNote, screened in Covidence, and data synthesized using Review Manager. Eligible studies examined MMN or MNP interventions during pregnancy, lactation, or early childhood, reporting cognitive, motor, or socio-emotional outcomes in children aged 4–14. Results: Ten studies met inclusion criteria: six on maternal supplementation, three on early childhood interventions, and one combining both. Most were conducted in Asia, with one in Tanzania and one in Peru. Although most findings were not statistically significant, two large UNIMMAP-based trials indicated modest long-term improvements in procedural memory and intelligence, while one early childhood point-of-use MNP trial suggested enhanced pre-academic skills. Conclusion: Maternal MMN supplementation may modestly enhance specific domains of cognitive development, whereas evidence on the long-term effects of MMN and point-of-use MNPs on cognitive development remain limited, highlighted the necessity for further research.


  • Open Access

    Effect of Aflasafe TZ01® on Aflatoxin Reduction and Emerging Challenges with Fusarium Mycotoxins in Maize from Rural Tanzania

    by Sambwe Fundikira, Martin Kimanya, Rashid Suleiman, Marthe De Boevre, Kokeb Tesfamariam, Sarah De Saeger

    Aflatoxins are carcinogenic secondary metabolites produced by Aspergillus species and are common contaminants of many crops including maize. Atoxigenic Aspergillus flavus strains, formulated as biocontrol products such as Aflasafe® TZ01, that comprises a mixture of four native atoxigenic strains, are used as pre-harvest agents to suppress toxigenic strains and reduce aflatoxin levels. This study assessed the intended and potential unintended impacts of Aflasafe® TZ01 on mycotoxin contamination in maize. A total of 158 samples 79 from treated and 79 from untreated fields were collected from Chemba and Kiteto districts in Tanzania. Multi-mycotoxin analysis was conducted using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Detected toxins included aflatoxins (AFB1, AFB2, AFG1, AFG2), trichothecenes, and fumonisins (FB1, FB2, FB3). Non-parametric paired t-test analysis showed significant reductions in AFB1 (62%, p = 0.024) in treated samples. The mean concentrations of Fusarium mycotoxins such as NIV, T2, and ZEN were higher in treated maize. However, statistical analysis showed that these differences were only numerical trends, and were not significant (p > 0.05). These findings confirm the efficacy of Aflasafe® TZ01 in reducing aflatoxins, while underscoring the importance of continued monitoring for other mycotoxins as part of integrated mycotoxin management strategies to mitigate both aflatoxins and co-occurring toxins.


  • Open Access

    Incidence and mortality of acute aflatoxicosis: A systematic review

    by Tess Goessens, Kokeb Tesfamariam, Patrick Berka Njobeh, Limbikani Matumba, Nyadani Jali-Meleke, Yun Yun Gong, Zdenko Herceg, Chibundu N. Ezekiel, Sarah De Saeger, Carl Lachat, et al.


  • Open Access

    Comparison of Gestational Age Assessment Methods in the Second and Third Trimesters: Evaluating Alternative Approaches Against Ultrasound in Urban Burkina Faso

    by Cheick Ahmed Ouattara, Anderson Compaoré, Lionel Olivier Ouédraogo, Moctar Ouédraogo, Hermann Ouattara, Moussa Coulibaly, Lishi Deng, Zakari Nikiéma, Giles T. Hanley-Cook, Alemayehu Argaw, et al.

    Background: Accurate determination of gestational age by way of ultrasound is challenging in resource-limited settings like Burkina Faso, leading to the use of alternative methods, though their accuracy and agreement remain poorly established. This practice leads to inadequate risk assessment during pregnancy and failure to identify preterm birth, potentially contributing to high neonatal mortality rates. The purpose of this study was to determine the agreement among alternative methods for gestational age estimation and the Alliance for Maternal and Newborn Health Improvement (AMANHI) method in Burkina Faso. Methods: Data were obtained from a prospective cohort study involving pregnant women in the second or third trimester in Bobo-Dioulasso to evaluate the agreement of last menstrual period (LMP), symphysis-fundal height (SFH), Dubowitz, Hadlock, and AMAHNI methods to estimate gestational age. The degree of agreement was assessed using the Bland–Altman method and intraclass correlation coefficients. The AMANHI method, validated for late pregnancy, was used as the reference standard. Results: A total of 768 pregnant women were included in the analysis. Plots showed a lack of agreement between the AMANHI method and all other methods, with 95% limits of agreement ranging from −7.6 to +9.8 weeks. Additionally, the incidence of preterm birth was consistently higher when assessed using the alternative methods compared with the AMANHI method. Conclusions: The clinical methods (SFH, LMP, Dubowitz) disagree with the ultrasound methods (AMANHI, Hadlock), but the ultrasound methods produce more similar results. The routine application of other methods is likely to result in an overestimation of preterm birth incidence compared with AMANHI. These findings highlight the urgent need to improve access to obstetric ultrasound and to provide comprehensive training in the application of the AMANHI method for accurate late-term gestational age estimation in Burkina Faso.


  • Open Access

    Rapid LA-REIMS-based metabolic fingerprinting of serum discriminates aflatoxin-exposed from non-exposed pregnant women: a prospective cohort from the Butajira Nutrition, Mental Health, and Pregnancy (BUNMAP) Study in rural Ethiopia

    by Kokeb Tesfamariam, Vera Plekhova, Seifu H. Gebreyesus, Carl Lachat, Eugenio Alladio, Alemayehu Argaw, Bilal Shikur Endris, Meselech Roro, Sarah De Saeger, Lynn Vanhaecke, et al.

    To date, the changes in maternal metabolic response associated with prenatal aflatoxin exposure remain largely unknown. This study investigated the effects of prenatal aflatoxin exposure on the maternal serum metabolome in rural Ethiopia. A total of 309 pregnant women were enrolled prospectively, and their serum aflatoxin concentrations were measured using targeted liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS). Serum metabolic fingerprints were obtained using laser-assisted rapid evaporative ionization mass spectrometry (LA-REIMS), followed by combination of univariate and multivariate statistical modelling to evaluate changes in circulating metabolic features between aflatoxin-exposed and unexposed mothers and to select discriminatory metabolic features. The analysis revealed that 81.8% of women were exposed to aflatoxins, with a median concentration of 12.9 pg/mg albumin. The orthogonal partial least square discriminant analysis (OPLS-DA) regression model demonstrated significant disparities in the serum metabolome when comparing Ethiopian pregnant women with low vs high aflatoxin exposure. Thirty-two differentially expressed metabolic features were identified, affecting aminoacyl-tRNA biosynthesis pathway. Several discriminatory metabolites have been identified, including glutamine, tryptophan, tyrosine, carnosine, and 1-methylnicotinamide. In conclusion, our findings indicate that aflatoxin exposure during pregnancy have shown disparities in the maternal serum metabolome, primarily affecting protein synthesis. Further research is needed to identify specific metabolite biomarkers and elucidate the underlying mechanisms.


  • Dietary aflatoxins exposure, environmental enteropathy, and their relation with childhood stunting

    by Markos Makiso Urugo, Tilahun A. Teka, Tefera Belachew Lema, Janerose Nasimiyu Lusweti, Jasmina Djedjibegovíc, Carl Lachat, Kokeb Tesfamariam, Addisalem Mesfin, Tess Astatkie, Mosaad A. Abdel-Wahhab

    Childhood stunting is a global phenomenon affecting more than 149 million children under the age of 5 worldwide. Exposure to aflatoxins (AFs) in utero, during breastfeeding, and consumption of contaminated food affect the gut microbiome, resulting in intestinal dysfunction and potentially contributing to stunting. This review explores the potential relationship between AF exposure, environmental enteropathy and childhood stunting. AFs bind to DNA, disrupt protein synthesis and elicit environmental enteropathy (EE). An EE alters the structure of intestinal epithelial cells, impairs nutrient uptake and leads to malabsorption. This article proposes possible intervention strategies for researchers and policymakers to reduce AF exposure, EE and childhood stunting, such as exposure reduction, the implementation of good agricultural practices, dietary diversification and improving environmental water sanitation and hygiene.


  • Open Access

    Dietary mycotoxin exposure and human health risks: A protocol for a systematic review

    by T. Goessens, T. Mouchtaris-Michailidis, K. Tesfamariam, N.N. Truong, F. Vertriest, Y. Bader, S. De Saeger, C. Lachat, M. De Boevre